BIIB-024

CAS: 1096708-71-2

Ref. 3D-FB103923

Produktinformation

• Name: BIIB-024

Beschreibung

BIIB-024 is a monoclonal antibody that targets mutant melanoma cells. It binds to the tumor and prevents it from growing, as well as preventing the cancer cells from spreading. BIIB-024 has shown effectiveness in clinical studies by reducing tumor size and skin reactions in patients with melanoma. The effective dose of BIIB-024 is 10 milligrams per kilogram of body weight. BIIB-024 also inhibits protein synthesis in tumor cells, which may be due to its ability to bind to cytosolic proteins.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 506.29 g/mol
• Formel: C₁₇H₁₂Cl₂F₃N₇O₂S
• Reinheit: Min. 95%